欢迎来到《四川大学学报(医学版)》 2025年6月22日 星期日

Numb蛋白在上皮性卵巢癌中的表达及其与CD117、CD133、ALDH1的关系

敬宏, 牛晓宇, 陈亚丽等

敬宏, 牛晓宇, 陈亚丽等. Numb蛋白在上皮性卵巢癌中的表达及其与CD117、CD133、ALDH1的关系[J]. 四川大学学报(医学版), 2016, 47(6): 878-882.
引用本文: 敬宏, 牛晓宇, 陈亚丽等. Numb蛋白在上皮性卵巢癌中的表达及其与CD117、CD133、ALDH1的关系[J]. 四川大学学报(医学版), 2016, 47(6): 878-882.
JING Hong, NIU Xiao-yu, CHEN Ya-li. et al. Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship[J]. Journal of Sichuan University (Medical Sciences), 2016, 47(6): 878-882.
Citation: JING Hong, NIU Xiao-yu, CHEN Ya-li. et al. Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship[J]. Journal of Sichuan University (Medical Sciences), 2016, 47(6): 878-882.

栏目: 论著

Numb蛋白在上皮性卵巢癌中的表达及其与CD117、CD133、ALDH1的关系

Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship

  • 摘要: 目的 探讨膜相关蛋白Numb在上皮性卵巢癌中的表达及其与卵巢癌干细胞标志物CD117、CD133、乙醛脱氢酶1(ALDH1)的关系。方法 选择四川大学华西第二医院妇科住院的136例卵巢肿瘤患者及无卵巢肿瘤患者22例为研究对象,根据摘除卵巢的病理组织学检查结果,将其分为上皮性卵巢癌组(n=92)、交界性卵巢肿瘤组(n=23)、良性卵巢肿瘤组(n=21)及正常卵巢组(n=22)。采用免疫组化SP法检测患者卵巢组织中Numb、CD117、CD133及ALDH1蛋白的表达水平,统计分析几种蛋白的表达差异及相关性。结果 ①Numb蛋白在上皮性卵巢癌组阳性表达率高于良性卵巢肿瘤组及正常卵巢组,交界性卵巢肿瘤组Numb蛋白阳性表达率高于正常卵巢组,且差异均有统计学意义(P<0.05)。②Numb蛋白阳性表达率在上皮性卵巢癌患者中FIGO分期为Ⅰ~Ⅱ期患者低于Ⅲ~Ⅳ期患者,无淋巴结转移患者低于有淋巴结转移患者,且阳性表达率差异均有统计学意义(P<0.05);而不同年龄、组织病理学类型、病理分级及残留灶大小之间比较,差异则无统计学意义(P>0.05)。③上皮性卵巢癌患者卵巢组织中Numb蛋白与CD117及CD133阳性表达无相关性(r=0.116,P=0.261;r=0.083,P=0.425);而Numb蛋白阳性表达与ALDH1表达呈正相关关系(r=0.296,P=0.003)。结论 Numb蛋白的表达与上皮性卵巢癌的发生、侵袭和转移有关,与卵巢癌干细胞标志物ALDH1表达呈正相关,有可能影响患者的预后。

     

    Abstract: Objective To explore the expression level of membrane-associated protein Numb in epithelial ovarian carcinoma and its relationship with ovarian cancer stem cell markers CD117, CD133, acetaldehyde dehydrogenase 1(ALDH1). Methods A total of 136 patients who had ovarian tumors and 22 patients who had not ovarian tumors in Department of Gynaecology and Obstetrics, West China Second University Hospital, Sichuan University were chosen as the study subjects. According to the histopathologic examination results, they were divided into epithelial ovarian carcinoma group (n=92), ovarian borderline tumor group (n=23), ovarian benign tumor group (n=21) and normal ovary group (n=22). Expression levels of Numb protein, CD117, CD133 and ALDH1 in ovarian tissue were detected by immunohistochemical SP method and these several kinds of protein expression differences and correlation statistical analysis were performend. Results ① The positive expression rate of Numb protein in epithelial ovarian carcinoma group was higher than that in benign tumor or normal ovary group, also Numb protein positive expression rate in ovarian borderline tumor group was higher than that in normal ovary group, and the differences were statistically significant (P<0.05). ② Numb protein positive expression rate in ovarian tissue in patients with epithelial ovarian carcinoma FIGO stageⅠ-Ⅱ was lower than that in stage Ⅲ-Ⅳ, also the same in no lymph nodes metastasis compared with lymph nodes invasion, and the differences of positive expression rate were statistically significant (P<0.05). While there were no significant differences among different age, histopathological types, pathological grades and residual tumor size (P>0.05). ③ There was no correlation between Numb protein and CD117 and CD133 positive expression rate in epithelial ovarian carcinoma tissue 〔correlation coefficient (r)=0.116, P=0.261; r=0.083, P=0.425〕. However, the positive expression rate of Numb protein and ALDH1 was positively correlated (r=0.296, P=0.261). Conclusion The expression of Numb protein may involve in the occurrence, invasion and mechanisms of ovarian cancer, positively correlated with ovarian cancer stem cell markers ALDH1, and may affect the prognosis of patients.

     

  • 期刊类型引用(11)

    1. 关慧鑫,韩世愈. 卵巢癌肿瘤干细胞及其标志物与卵巢癌靶向治疗的研究进展. 中国生育健康杂志. 2022(01): 90-93+97 . 百度学术
    2. 范小庆,周国凤,陶珊珊,熊秋云. 乳腺癌组织AGR-2的表达及其临床意义. 中国医学创新. 2021(15): 120-123 . 百度学术
    3. 李婷,苏宏伟,刘军超,曹娟,李晨,刘鑫,李向东. 乙醛脱氢酶1和肿瘤坏死因子相关诱导凋亡配体在膀胱癌组织中的表达及其临床意义. 现代生物医学进展. 2019(03): 498-501 . 百度学术
    4. 杜瑞,凌月仙,张江宇,吴坤河,张艳红,陈文静. 性腺母细胞瘤的临床病理观察. 诊断病理学杂志. 2019(08): 519-522 . 百度学术
    5. 马琳,刘杏巧,张志革,高敏,郑炜. 干细胞标志物CD44及CD90在卵巢癌组织中的表达及临床意义. 国际检验医学杂志. 2018(04): 415-418 . 百度学术
    6. 贺媛媛,张义男,朱琳飞,陆欣欣,周欣. Numb蛋白在卵巢浆液性肿瘤中的表达及临床意义. 解剖科学进展. 2018(02): 173-176 . 百度学术
    7. 马琳,刘杏巧,张志革,高敏. CD133和ALDH1在卵巢癌组织中的表达及与预后的相关性研究. 标记免疫分析与临床. 2018(08): 1227-1230+1245 . 百度学术
    8. 梁健梅,周志君,卢宇青. CD133在子宫内膜癌患者中的表达及患者侵袭转移高危因素研究. 中国医药科学. 2017(13): 178-180+218 . 百度学术
    9. 刘妍,刘颖,俊梅. 卵巢癌患者血清CD133和miR-145的表达与临床病理特征及预后的关系. 中国妇幼保健. 2017(14): 3155-3158 . 百度学术
    10. 敬宏,牛晓宇. 卵巢癌肿瘤干细胞及其标志物在卵巢癌诊疗中作用的研究进展. 中华妇幼临床医学杂志(电子版). 2017(02): 226-230 . 百度学术
    11. 范小庆,陶姗姗,熊秋云,雷秋模. Numb蛋白在乳腺癌组织的表达及其临床病理相关性分析. 中国医学创新. 2017(23): 25-28 . 百度学术

    其他类型引用(4)

计量
  • 文章访问数:  3398
  • HTML全文浏览量:  325
  • PDF下载量:  32
  • 被引次数: 15
出版历程
  • 发布日期:  2016-11-19

目录

    /

    返回文章
    返回